{
    "nctId": "NCT05807074",
    "briefTitle": "Impact of Topical Tranexamic Acid in Breast Reconstruction",
    "officialTitle": "The Impact of Tranexamic Acid in Reducing Hematoma and Seroma Formation in Reconstructive Post-oncologic Breast Surgery",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Number of participants with hematoma",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Histologically confirmed breast malignancy OR increased risk for breast cancer\n2. Age \\>= 18 years\n3. Scheduled to undergo bilateral mastectomy with plastic surgery closure or reconstruction\n4. Ability to understand a written informed consent document, and the willingness to sign it\n5. At least 4 weeks post-completion of chemotherapy or radiation therapy\n\nExclusion Criteria:\n\n1. Any significant medical condition or laboratory abnormalities, which places the subject at unacceptable risk if she were to participate in the study\n2. Any history of thromboembolic disease\n3. Current anticoagulant use\n4. Current use of chlorpromazine due to label contraindication\n5. Current use of any prothrombotic medical products due to label contraindication\n6. Documented or reported allergic reaction to tranexamic acid\n7. Male participants",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}